宣白承气加减方辅助改善脓毒症急性肺损伤的临床疗效观察

中华养生保健 ›› 2022, Vol. 40 ›› Issue (20): 1-4.

• 论著 • 下一篇

宣白承气加减方辅助改善脓毒症急性肺损伤的临床疗效观察

刘红栓¹, 李硕^1,*, 刘清泉², 杨鸿³

1.北京中医药大学东直门医院ICU,北京,100010;
2.北京中医医院急诊科,北京,101100;
3.中国医学科学院中心实验室,北京,100013

出版日期:2022-10-16 发布日期:2022-10-14
通讯作者: 李硕,E-mail：sure8801@126.com。
作者简介:刘红栓（1979.7-）,男,汉族,籍贯：河北省沧州市,硕士研究生,副主任医师,研究方向：中医内科。
基金资助:
北京市自然科学基金项目（7192083）

Clinical Observation of Xuanbai Chengqi Supplementing and Reducing Prescription in Improving Sepsis-Associated Acute Lung Injury

LIU Hong-shuan¹, LI Shuo^1,*, LIU Qing-quan², YANG Hong³

1. ICU, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, 100010, China;
2. Department of Emergency, Beijing Hospital of Traditional Chinese Medicine, Beijing, 101100, China;
3. Central Laboratory, Chinese Academy of Medical Sciences, Beijing, 100013, China

Online:2022-10-16 Published:2022-10-14

摘要/Abstract

摘要： 目的观察宣白承气加减方辅助改善脓毒症急性肺损伤（Sepsis-Associated Acute Lung Injury,S-ALI）的临床疗效。方法选取2020年1月~2021年12月北京中医药大学东直门医院收治的80例S-ALI患者作为研究对象,按照随机数表法随机分为治疗组和对照组,每组40例。对照组采用常规治疗,治疗组在常规治疗的基础上加用及宣白承气加减方,两组均治疗7 d。观察两组患者治疗前后氧合指数（PO₂/FiO₂）,呼吸频率（R）,24 h大便量,白细胞（WBC）、C反应蛋白（CRP）、谷丙转氨酶（ALT）、血肌酐（SCR）、急性生理与慢性健康评分（APACHE Ⅱ评分）,血清铁离子（Fe）等指标的变化情况。结果治疗后第7 d,治疗组患者的氧合指数（PO₂/FiO₂）较对照组高,24 h大便量较对照组多,呼吸频率较对照组低,差异有统计学意义（P<0.05）;治疗组WBC、CRP、APACHE Ⅱ评分、Fe较对照组低,差异有统计学意义（P<0.05）;治疗组患者ALT、SCR与对照组相比,差异无统计学意义（P>0.05）。结论宣白承气加减方可以改善患者肺功能、胃肠功能,可辅助抑制炎症反应。同时,宣白承气加减方具备一定的肝、肾安全性。

关键词: 脓毒症急性肺损伤, 宣白承气加减方, 氧合指数, 疗效

Abstract: Objective To observe the clinical efficacy of Xuanbai Chengqi decoction in improving (sepsis-associated acute lung injury, S-ALI). Methods A total of 80 S-ALI patients admitted to Dongzhimen Hospital of Beijing University of Chinese Medicine from January 2020 to December 2021 were selected as research subjects, and were randomly divided into treatment group and control group according to random number table method, with 40 patients in each group. The control group was treated with conventional treatment, and the treatment group was treated with Xuanbai Chengqi supplementing and reducing prescription on the basis of conventional treatment ,both groups were treated for 7 days.. The oxygenation index (PO₂/FiO₂), respiratory rate (R), 24-hour stool volume of 2 groups were observed before and after treatment. Changes of white blood cell (WBC), C-reactive protein (CRP), alanine aminotransferase (ALT), serum creatinine (SCR), acute physiology and chronic health score (APACHE Ⅱ score), serum iron ion (Fe) and other indicators. Results On the 7th day of treatment,the oxygenation index (PO₂/FiO₂), 24-hour stool volume and respiratory rate in the treatment group were higher than those in the control group and the differences were statistically significant (P<0.05); WBC, CRP, APACHE Ⅱ score and Fe in the treatment group were lower than those in the control group, the difference was statistically significant (P<0.05). There were no significant differences in ALT and SCR between the treatment group and the control group. Conclusion Xuanbai Chengqi supplementing and reducing prescription can help the patient to improve lung function, gastrointestinal function, and suppress the inflammatory response. At the same time, the prescription has a certain security to liver and kidney.

Key words: sepsis-associated acute lung Injury, Xuanbai Chengqi supplementing and reducing prescription, oxygenation Index, curative effect

中图分类号:

R278

刘红栓, 李硕, 刘清泉, 杨鸿. 宣白承气加减方辅助改善脓毒症急性肺损伤的临床疗效观察[J]. 中华养生保健, 2022, 40(20): 1-4.

LIU Hong-shuan, LI Shuo, LIU Qing-quan, YANG Hong. Clinical Observation of Xuanbai Chengqi Supplementing and Reducing Prescription in Improving Sepsis-Associated Acute Lung Injury[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(20): 1-4.

参考文献

[1] Singer M, Deutschman C S, Seymour C W, et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.
[2] 刘大为,邱海波,严海.中国重症医学专科资质培训教材[M].2版.北京:人民卫生出版社,2016:112-113.
[3] Xie J F, Wang H L, Kang Y, et al.The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey[J]. Crit Care Med,2020,48(3): e209-e218.
[4] 吴勉华,王新月.中医内科学[M].9版.北京:中国中医药出版社,2012: 32-35.
[5] 曹钰,柴艳芬,邓颖,等.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567-588.
[6] 王佳兴,付鹤鹏,王蓓蕾,等.卡络磺钠通过抑制parkin介导的线粒体自噬减轻脓毒症大鼠的肺损伤[J].中国病理生理杂志,2021,37(8): 1447-1454.
[7] 王宁,丁显飞,崔玉青,等.甲磺酸加贝酯改善脓毒症急性肺损伤大鼠的代谢组学研究[J].中华急诊医学杂志,2022,31(2):191-196.
[8] 何荷,梁隆斌,刘杨,等.绿原酸通过ROS/TXNIP/NLRP3信号通路介导的细胞焦亡途径减轻脓毒症小鼠急性肺损伤[J].中国病理生理杂志,2021,37(8):1455-1461.
[9] 刘锐,林秀玉,孙兆瑞,等.牛磺酸对脓毒症大鼠急性肺损伤的保护作用机制[J].医学研究生学报,2021,34(12):1238-1243.
[10] 李成洁,陈健,吴勇,等.异丙酚抑制甲酰基肽受体1减轻脓毒症诱导的小鼠急性肺损伤[J].现代免疫学,2021,41(6):441-447.
[11] 李秋宇,金醒昉,朱惠容,等.不同剂量红花黄色素A对脓毒症大鼠炎性因子的影响及急性肺损伤的保护作用[J].吉林医学,2021, 42(11):2565-2569.
[12] 孔令博,晏军,张迪,等.中医药治疗脓毒症领域临床优势的探讨[J].中国实验方剂学杂志,2022,28(5):211-218.
[13] 黄晗,李凤芝,李杨,等.灵芝多糖对脓毒症急性肺损伤大鼠肺功能及TLR4/NF-κB通路的影响[J].中草药,2021,52(8):2351-2356.
[14] 段金旗,林艳.姜黄素对脓毒症急性肺损伤大鼠的保护作用[J].中国免疫学杂志,2020,36(19):2380-2383,2388.
[15] 陈新玉,陈晓桦,钟飞雁,等.宣白承气汤保留灌肠在脓毒症肺损伤患者的临床研究[J].中医临床研究,2017,9(36):66-68.
[16] 赖芳,曾瑞峰,张燕,等.益气通腑泻热法治疗脓毒症致急性肺损伤/急性呼吸窘迫综合征的临床研究[J].中医药导报,2021,27(8):75-80.
[17] 潘广涛,刘宇寒,尚罗锐,等.大承气汤通过减轻凋亡对急性肺损伤大鼠的保护机制研究[J].时珍国医国药,2021,32(8):1825-1829.
[18] 王佳,高恒波,林雪容,等.血必净注射液减轻脓毒症诱导的小鼠急性肺损伤的作用及机制[J].华西医学,2021,36(11):1533-1538.
[19] 龚光远,欧红,张文军,等.血必净联合乌司他丁治疗脓毒症急性肺损伤临床研究[J].中国药业,2022,31(4):105-108.
[20] 赵红芳,江其敏,刘清泉.刘清泉教授应用中医药治疗脓毒症的临床经验[J].中国中医急症,2017,26(9):1563-1565.

宣白承气加减方辅助改善脓毒症急性肺损伤的临床疗效观察

Clinical Observation of Xuanbai Chengqi Supplementing and Reducing Prescription in Improving Sepsis-Associated Acute Lung Injury

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙涛, 蔡珂, 刘姿杉, 周春丽, 孙龙军. 金丹排石汤治疗湿热型输尿管结石的临床效果[J]. 中华养生保健, 2024, 42(9): 12-16.
[2]	张立伟, 王颖, 李懿娇, 徐金婵. 埋针联合耳穴压豆辅助治疗慢阻肺疾病痰浊阻肺证患者的疗效观察[J]. 中华养生保健, 2024, 42(9): 21-24.
[3]	覃桂水, 陶怡, 郑美华. “以通为用”指导下不同刮痧方法在气滞血瘀型肩周炎患者中的临床应用[J]. 中华养生保健, 2024, 42(9): 31-34.
[4]	李伟. 中医药透配合针灸治疗老年性膝关节骨性关节炎的临床观察[J]. 中华养生保健, 2024, 42(9): 34-37.
[5]	杨楠. 滋阴清热汤治疗月经不调的临床疗效及对血清激素水平的影响研究[J]. 中华养生保健, 2024, 42(9): 37-39.
[6]	孙欢欢. 依达拉奉联合阿托伐他汀治疗脑梗死恢复期患者的相关研究[J]. 中华养生保健, 2024, 42(9): 187-190.
[7]	李晓琳, 李斯文, 冯妮. 四君子汤联合替吉奥治疗晚期胃癌患者的临床疗效及安全性分析[J]. 中华养生保健, 2024, 42(8): 24-27.
[8]	喻霞, 齐慧丽, 张春红. 紫杉醇注射液联合卡铂治疗卵巢癌对患者免疫功能的影响[J]. 中华养生保健, 2024, 42(8): 40-44.
[9]	马周宇. 非锁定钢板内固定术和锁定钢板内固定术治疗跟骨粉碎性骨折的临床效果比较研究[J]. 中华养生保健, 2024, 42(8): 174-177.
[10]	杨廷智, 马平, 付有娟, 罗兵, 何文清. 敷膝热奄包联合推拿治疗膝关节炎的临床疗效观察[J]. 中华养生保健, 2024, 42(7): 1-4.
[11]	邵光辉. 云南白药胶囊辅助经皮微创内固定术对胫骨平台骨折患者愈合的影响[J]. 中华养生保健, 2024, 42(7): 23-26.
[12]	杨翠红, 于莉芝. 进阶式肺康复训练与俯卧位通气在重度ARDS患者中的应用研究[J]. 中华养生保健, 2024, 42(7): 105-108.
[13]	闵晶晶, 杜林栋, 聂成梅. 益肾扶阳粉隔药灸法对肾病综合征水肿的治疗效果观察[J]. 中华养生保健, 2024, 42(6): 1-4.
[14]	张建忠, 任明媛, 王鑫, 徐艳艳, 李小静, 苗国英, 王利涛. 微针联合卤米松乳膏及白灵片治疗肢端白癜风效果分析[J]. 中华养生保健, 2024, 42(6): 9-12.
[15]	俞生, 田仁丹. 熏洗法辅助针灸及康复训练法对中风后遗症临床疗效的影响研究[J]. 中华养生保健, 2024, 42(6): 34-37.